[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100584989":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":12,"locations":7,"responsibleParty":21,"collaborators":7,"id":23,"slug":7,"hasResults":24,"nctId":25,"briefTitle":26,"officialTitle":26,"acronym":27,"eligibilityCriteria":28,"healthyVolunteers":24,"sex":29,"minAge":7,"maxAge":30,"enrollmentInfo":31,"targetDuration":30,"studyType":34,"phases":7,"briefSummary":35,"conditions":36,"keywords":43,"overallStatus":45,"whyStopped":7,"lastUpdateSubmitDate":46,"lastUpdatePostDateStruct":47,"startDateStruct":50,"completionDateStruct":52,"leadSponsor":54,"locationsCount":7},{"fullName":5,"class":6},"Precia Group","INDUSTRY",null,[9],{"name":10,"affiliation":5,"role":11},"Donna Russell, MPA","PRINCIPAL_INVESTIGATOR",[13,17],{"name":10,"role":14,"phone":15,"phoneExt":7,"email":16},"CONTACT","12069922825","donna.russell@preciagroup.com",{"name":18,"role":14,"phone":19,"phoneExt":7,"email":20},"Samantha Udondem, MPH","9403431959","samantha.udondem@preciagroup.com",{"type":22,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100584989",false,"NCT06896526","Comprehensive Outcomes Monitoring for Peri- and Postnatal Invasive Group B Strep Sequelae (COMPPASS) Registry","COMPPASS","Inclusion Criteria:\n\n1. A child below the age of 19 who was either diagnosed with or received a lab test result confirming an iGBS infection, or being able to describe their child's condition and experience with iGBS infection at, or within 90 days of, birth.\n\n   or A child who was diagnosed as having invasive Group B Strep infection within the first 90 days after delivery and later passed away because of the infection or Parent who has experienced a stillbirth due to iGBS infection\n2. A sibling(s) from a multi-gestation pregnancy where at least one child was diagnosed as having invasive Group B Strep infection\n3. Parent or caregiver who understands and electronically signs the inform consent document\n4. In addition to parental or caregiver consent, children between the ages of 13-17 years who are able to understand and provide assent to take part in the study, as confirmed by an electronic signature by their consenting parent or caregiver.\n\nExclusion Criteria:\n\n1\\. A child affected by iGBS infection currently over the age of 18.","ALL","18 Years",{"count":32,"type":33},10000,"ESTIMATED","OBSERVATIONAL","The goal of this registry is to collect and store important medical and non-health information on children from 0 to 18 years of age affected by early- (up to 24 hours after birth) and late-onset (up to 90 days after birth) invasive Group B Streptococcus (iGBS) and their families. Data collected from families of children affected by perinatal iGBS will support further research to understand the short- and long-term impact of iGBS disease on affected children and its impact on their families. Participants will be invited to complete obstetric and pregnancy-related questionnaires as well as validated neurodevelopmental surveys at various timepoints throughout their participation in the registry.",[37,38,39,40,41,42],"Invasive Group B Streptococcus Disease","Group B Streptococcus","Group B Streptococcal Infection","Group B Streptococcus (GBS) Disease","Group B Streptococcal Infection, Early-Onset","Group B Streptococcal Infection, Late-Onset",[37,44],"Invasive Group B Streptococcus Registry","NOT_YET_RECRUITING","2025-03-19",{"date":48,"type":49},"2025-03-26","ACTUAL",{"date":51,"type":33},"2025-04-01",{"date":53,"type":33},"2035-03-31",{"name":5,"class":6}]